Skip to main content

MedCloud Minute

The MedCloud Minute blog is researched, fact-checked, edited and updated by the editors of MedCloudInsider.com, with writing assistance from AI. To submit your company's press release for consideration, contact [email protected].


MedCloud Minute


DarwinHealth Applies AI to Map Drug-Resistant Cancer Cell States

Key Takeaways

  • DarwinHealth introduces Quantum Cancer Biology, combining AI and systems biology for cell-state-based precision oncology.
  • VIPER technology identifies Master Regulator proteins across malignant cell states to uncover potential therapeutic vulnerabilities.
  • AI-driven drug combination analysis targets multiple cancer cell populations to address treatment resistance in difficult malignancies.

DarwinHealth, an AI-centric biotechnology company, has introduced Quantum Cancer Biology, a precision oncology framework that uses AI and systems biology to analyze multiple malignant cell states within individual tumors rather than focusing primarily on genetic mutations.


More

Posted by MedCloudInsider Editors on 08/31/20260 comments


Share

Monod Bio Licenses AI-Designed Proteins for Drug Discovery Assays

Key Takeaways

  • Monod Bio licenses AI-designed LuxSit and NovoBodies protein technologies to SignalChem Biotech for drug discovery research.
  • SignalChem can use Monod Bio technologies in custom luminescent assays and protein-fusion services for research customers.
  • AI-powered de novo protein design expands into CRO services through SignalChem and Sino Biological’s global life sciences network.

Monod Bio, a Seattle-based AI-enabled protein design company, has licensed two of its AI-designed protein technologies to SignalChem Biotech, a subsidiary of Sino Biological, for use in custom drug discovery and life sciences research services. The nonexclusive agreement covers Monod Bio’s LuxSit de novo luciferase technology and NovoBodies.


More

Posted by MedCloudInsider Editors on 08/31/20260 comments


Share

Precision BioLogic Expands Hemostasis Diagnostics Through Acquisitions

Key Takeaways

  • Precision BioLogic expands hemostasis diagnostics by combining capabilities from Affinity Biologicals and George King Bio-Medical.
  • CRYOcheck Chromogenic Factor VIII assay supports accurate hemophilia testing as newer therapies including Mim8 emerge.
  • ISTH 2026 research explored anticoagulant-resistant lupus anticoagulant testing and factor VIII therapy effects on inhibitor assays.

Precision BioLogic, a developer of hemostasis diagnostic products, is expanding its hemostasis diagnostics and research business by combining capabilities from two acquired subsidiaries, Affinity Biologicals and George King Bio-Medical.


More

Posted by MedCloudInsider Editors on 08/31/20260 comments


Share

HearingLife Introduces Oticon Reveal Hearing Aid with Dual AI Processing

Key Takeaways

  • HearingLife offers Oticon Reveal hearing aids with Dual AI technology for simultaneous speech and environmental sound processing.
  • Oticon Reveal uses BrainHearing methodology to preserve speech clarity while maintaining broader environmental sound context.
  • Rechargeable Oticon Reveal supports audio streaming and Oticon CROS technology for people with single-sided hearing loss.

HearingLife, a hearing care company, has begun offering Oticon Reveal, a hearing aid that uses what the company describes as Dual AI technology to process speech and environmental sounds simultaneously.


More

Posted by MedCloudInsider Editors on 08/25/20260 comments


Share

Oracle Health Expands Clinical AI Agent with Coding and Chart Review

Key Takeaways

  • Oracle Health expands Clinical AI Agent with automated medical coding, voice dictation, and AI-powered patient chart review.
  • Oracle’s AI agents use semantic reasoning and shared clinical context to automate documentation workflows while maintaining clinician control.
  • AI-generated medical coding could reduce manual work but requires human review, auditability, compliance, and patient data protection.

Oracle Health, a provider of health care technology and clinical software, has expanded its Clinical AI Agent with capabilities for automated coding, dictation and chart review, broadening the system beyond its existing clinical documentation functions.


More

Posted by MedCloudInsider Editors on 08/25/20260 comments


Share

Insilico Medicine Adds Biological Age to Virtual Cell Modeling

Key Takeaways

  • Insilico Medicine adds biological age to virtual cell models for AI-powered aging and disease research.
  • Multi-agent AI platform coordinates biological data and computational workflows to generate virtual aging cell models.
  • Virtual Aging Cell technology could support age-related disease research, though computational predictions still require experimental validation.

Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), has introduced biological age into its virtual cell research and previewed a multi-agent AI platform for generating virtual aging cells, extending its use of artificial intelligence for modeling human biology.


More

Posted by MedCloudInsider Editors on 08/18/20260 comments


Share

Kyndryl to Acquire Healthcare IT Leaders to Expand Health Care Consulting Business

Key Takeaways

  • Kyndryl will acquire Healthcare IT Leaders to expand healthcare technology consulting, managed services, and AI-led modernization capabilities.
  • Healthcare IT Leaders adds electronic health records, cloud, data analytics, and enterprise application expertise to Kyndryl.
  • Acquisition strengthens Kyndryl’s healthcare modernization strategy as providers address legacy systems, interoperability, security, and AI adoption.

More

Posted by MedCloudInsider Editors on 08/11/20260 comments


Share

ICON Partners with Anthropic to Bring Claude Into Clinical Development

Key Takeaways

  • ICON partners with Anthropic to integrate Claude into regulated clinical development and drug research workflows.
  • ICON’s Orbis agentic AI platform will support site intelligence, predictive analytics, protocol optimization, and ecosystem integration.
  • Claude Code, Claude, and Claude Science will deliver role-based generative AI across ICON’s development, knowledge, and clinical teams.

ICON, a clinical research organisation, has entered a multi-year collaboration with Anthropic to integrate Claude into clinical development workflows, extending the use of generative AI across the contract research organization's operations.


More

Posted by MedCloudInsider Editors on 08/10/20260 comments


Share

QuadMed Adds Text Messaging to Employee Healthcare Platform

Key Takeaways

  • QuadMed launches SMS healthcare messaging to simplify patient access to employer-sponsored health centers and care teams.
  • Enhanced patient messaging supports appointment management through SMS and confidential clinical conversations through secure messaging.
  • QuadMed’s digital healthcare experience combines convenience and security without requiring patients to download another mobile application.

QuadMed, a leader in employer-sponsored healthcare, has introduced a text messaging capability designed to make it easier for employees and their families to connect with healthcare services offered through its employer-sponsored health centers.


More

Posted by MedCloudInsider Editors on 08/10/20260 comments


Share

POMDOCTOR Outlines AI Data Flywheel for Healthcare Platform Growth

Key Takeaways

  • POMDOCTOR’s healthcare intelligence flywheel uses wearable health data to continuously strengthen AI-driven analytics and personalized insights.
  • AI analytics process physiological and behavioral data to support patient risk assessment and chronic disease management.
  • POMDOCTOR’s self-reinforcing digital health strategy expands healthcare data for personalized services and future AI development.

POMDOCTOR Limited, a digital healthcare company focused on advancing AI-enabled healthcare solutions, has detailed what it calls a healthcare intelligence flywheel, a strategy for using data generated across its healthcare platform to continually improve AI models and expand its digital health services.


More

Posted by MedCloudInsider Editors on 08/10/20260 comments


Share

Signant Health Adds Agentic AI for Clinical Supply Forecasting

Key Takeaways

  • Signant Health launches Forecasting & Planning Assist to optimize clinical trial supply forecasting with agentic AI.
  • AI-powered forecasting improves clinical supply planning, inventory optimization, and patient enrollment risk management.
  • Forecasting & Planning Assist streamlines global clinical trial operations by reducing medication waste and improving supply availability.

Signant Health, a provider of eClinical solutions for clinical research, has introduced Forecasting & Planning Assist, an AI-powered capability designed to help clinical supply professionals improve forecasting and planning for global clinical trials. Forecasting & Planning Assist™ puts the full analytical power of the technology at the fingertips of clinical supply experts, enabling them to query data, execute configuration tasks, and monitor supply and enrollment risks across their portfolio in seconds through plain-language prompts, with complete oversight and control throughout.



More

Posted by MedCloudInsider Editors on 08/03/20260 comments


Share

Labcorp Expands Consumer Genetic Testing with New Hereditary Risk Panel

Key Takeaways

  • Labcorp launches the Marker Genetic Health Panel, expanding direct-to-consumer hereditary genetic testing and preventive healthcare services.
  • Clinical-grade genetic testing identifies inherited cancer, cardiovascular and hereditary disease risks with genetic counseling support.
  • Marker by Labcorp combines genetic testing, digital results and expert counseling for proactive consumer health management.

Labcorp, a global leader of innovative and comprehensive laboratory services, has expanded its consumer health offerings with the launch of the Marker by Labcorp Genetic Health Panel, a direct-to-consumer test designed to identify inherited genetic risks associated with certain hereditary conditions. The tool was developed to help address this gap by combining clinical genetic testing, specimen collection and genetic counseling into a single consumer healthcare experience.



More

Posted by MedCloudInsider Editors on 07/29/20260 comments


Share